LT3324938T - Vietinio veikimo kompozicijos ir gydymo būdai - Google Patents

Vietinio veikimo kompozicijos ir gydymo būdai

Info

Publication number
LT3324938T
LT3324938T LTEPPCT/US2016/042843T LT16042843T LT3324938T LT 3324938 T LT3324938 T LT 3324938T LT 16042843 T LT16042843 T LT 16042843T LT 3324938 T LT3324938 T LT 3324938T
Authority
LT
Lithuania
Prior art keywords
treatments
compositions
local action
local
action
Prior art date
Application number
LTEPPCT/US2016/042843T
Other languages
English (en)
Inventor
Hemant ALUR
James HARWICK
Original Assignee
Trilogic Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trilogic Pharma Llc filed Critical Trilogic Pharma Llc
Publication of LT3324938T publication Critical patent/LT3324938T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/US2016/042843T 2015-07-20 2016-07-18 Vietinio veikimo kompozicijos ir gydymo būdai LT3324938T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562194518P 2015-07-20 2015-07-20
PCT/US2016/042843 WO2017015232A1 (en) 2015-07-20 2016-07-18 Topical formulations and treatments

Publications (1)

Publication Number Publication Date
LT3324938T true LT3324938T (lt) 2021-11-25

Family

ID=57835134

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2016/042843T LT3324938T (lt) 2015-07-20 2016-07-18 Vietinio veikimo kompozicijos ir gydymo būdai

Country Status (11)

Country Link
US (3) US11129896B2 (lt)
EP (1) EP3324938B1 (lt)
CA (2) CA3209380A1 (lt)
DK (1) DK3324938T3 (lt)
ES (1) ES2891754T3 (lt)
HU (1) HUE056401T2 (lt)
LT (1) LT3324938T (lt)
MX (2) MX390004B (lt)
PL (1) PL3324938T3 (lt)
PT (1) PT3324938T (lt)
WO (1) WO2017015232A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056401T2 (hu) 2015-07-20 2022-02-28 Trilogic Pharma Llc Topikális készítmények és kezelések
JP6991148B2 (ja) 2016-02-09 2022-01-12 ブラッコ・スイス・ソシエテ・アノニム セレクチン標的化のための組み換えキメラタンパク質
AU2022319690A1 (en) * 2021-07-26 2024-03-14 Dare Bioscience, Inc. Compositions And Techniques For Vaginal Insertion
WO2023009445A1 (en) * 2021-07-26 2023-02-02 Daré Bioscience, Inc. Compositions for use in the treatment of bacterial vaginosis
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
AU2024211707A1 (en) * 2023-01-25 2025-08-07 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218023B1 (en) 1997-04-21 2001-04-17 Montell North America, Inc. Co-extruded laminate comprising at least one propylene graft copolymer layer
ATE306274T1 (de) * 1997-11-24 2005-10-15 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US8501230B2 (en) * 2007-12-03 2013-08-06 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
CN102525884A (zh) 2010-12-19 2012-07-04 复旦大学 一种用于阴道给药的温敏原位凝胶制剂
DE112012003070T5 (de) 2011-08-31 2014-04-30 Berry Plastics Corp. Polymermaterial für einen isolierten Behälter
KR20150079726A (ko) 2012-10-26 2015-07-08 베리 플라스틱스 코포레이션 단열 용기용 고분자 재료
HUE056401T2 (hu) 2015-07-20 2022-02-28 Trilogic Pharma Llc Topikális készítmények és kezelések

Also Published As

Publication number Publication date
ES2891754T3 (es) 2022-01-31
US20220040306A1 (en) 2022-02-10
HUE056401T2 (hu) 2022-02-28
PT3324938T (pt) 2021-09-21
DK3324938T3 (da) 2021-09-27
CA2993012A1 (en) 2017-01-26
US20250249105A1 (en) 2025-08-07
EP3324938A4 (en) 2019-03-13
MX390004B (es) 2025-03-04
MX2022001736A (es) 2022-03-11
CA2993012C (en) 2023-10-03
US20180207275A1 (en) 2018-07-26
WO2017015232A1 (en) 2017-01-26
CA3209380A1 (en) 2017-01-26
PL3324938T3 (pl) 2022-01-10
EP3324938A1 (en) 2018-05-30
US12303563B2 (en) 2025-05-20
EP3324938B1 (en) 2021-09-01
MX2018000800A (es) 2018-08-16
US11129896B2 (en) 2021-09-28

Similar Documents

Publication Publication Date Title
IL263680A (en) Combination therapies
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
LT3370770T (lt) Anti-cd38 antikūnų poodinės kompozicijos ir jų panaudojimas
IL249292A0 (en) Methods and devices for treating pulmonary edema
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
LT3317284T (lt) Benzoksazepino oksazolidinono junginiai ir jų naudojimo būdai
KR20180084891A (ko) 구조 조성물 및 방법
LT3518933T (lt) Gimdos fibromų ir endometriozės gydymo būdai
LT3283107T (lt) Kompozicija apimanti ipilimumabo ir nivolumabo kombinaciją
LT3212189T (lt) Pakeisti chromanai ir naudojimo būdas
LT3258962T (lt) Mišrios alergenų kompozicijos ir jų panaudojimo būdai
LT3102555T (lt) Junginių kompozicijos ir jų panaudojimas
PT3142637T (pt) Formulações e métodos de tratamento de queratina
LT3426285T (lt) Pegilintos urikazės kompozicijos ir dozės
IL247292A0 (en) Antireflective coating compositions and processes thereof
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
PL3394259T3 (pl) Kompozycje i sposoby zmniejszania ekspresji tau
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3182962T3 (da) Compositions and uses of amidine derivatives
LT3204386T (lt) Pakeistieji aminopurino junginiai, jų kompozicijos ir gydymo būdai jais
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
LT3324938T (lt) Vietinio veikimo kompozicijos ir gydymo būdai